Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:df0e79e5ab2e41ef86dd3dc64c5b821a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:df0e79e5ab2e41ef86dd3dc64c5b821a2021-11-10T18:37:50ZScreening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine10.1128/mBio.01458-212150-7511https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a2021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01458-21https://doaj.org/toc/2150-7511ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The antifungal arsenal to threat aspergillosis is very restricted. Azoles are the main therapeutic approach to control IPA, but the emergence of azole-resistant A. fumigatus isolates has significantly increased over recent decades. Therefore, new strategies are necessary to combat aspergillosis, and drug repurposing has emerged as an efficient and alternative approach for identifying new antifungal drugs. Here, we used a screening approach to analyze A. fumigatus in vitro susceptibility to 1,127 compounds. A. fumigatus was susceptible to 10 compounds, including miltefosine, a drug that displayed fungicidal activity against A. fumigatus. By screening an A. fumigatus transcription factor null library, we identified a single mutant, which has the smiA (sensitive to miltefosine) gene deleted, conferring a phenotype of susceptibility to miltefosine. The transcriptional profiling (RNA-seq) of the wild-type and ΔsmiA strains and chromatin immunoprecipitation coupled to next-generation sequencing (ChIP-Seq) of an SmiA-tagged strain exposed to miltefosine revealed genes of the sphingolipid pathway that are directly or indirectly regulated by SmiA. Sphingolipid analysis demonstrated that the mutant has overall decreased levels of sphingolipids when growing in the presence of miltefosine. The identification of SmiA represents the first genetic element described and characterized that plays a direct role in miltefosine response in fungi. IMPORTANCE The filamentous fungus Aspergillus fumigatus causes a group of diseases named aspergillosis, and their development occurs after the inhalation of conidia dispersed in the environment. Very few classes of antifungal drugs are available for aspergillosis treatment, e.g., azoles, but the emergence of global resistance to azoles in A. fumigatus clinical isolates has increased over recent decades. Repositioning or repurposing drugs already available on the market is an interesting and faster opportunity for the identification of novel antifungal agents. By using a repurposing strategy, we identified 10 different compounds that impact A. fumigatus survival. One of these compounds, miltefosine, demonstrated fungicidal activity against A. fumigatus. The mechanism of action of miltefosine is unknown, and, aiming to get more insights about it, we identified a transcription factor, SmiA (sensitive to miltefosine), important for miltefosine resistance. Our results suggest that miltefosine displays antifungal activity against A. fumigatus, interfering in sphingolipid biosynthesis.Thaila Fernanda dos ReisMaria Augusta Crivelente HortaAna Cristina ColabardiniCaroline Mota FernandesLilian Pereira SilvaRafael Wesley BastosMaria Vitória de Lazari FonsecaFang WangCelso MartinsMárcio L. RodriguesCristina Silva PereiraMaurizio Del PoetaKoon Ho WongGustavo H. GoldmanAmerican Society for MicrobiologyarticleAspergillus fumigatusdrug repurposingmiltefosinesphingolipidstranscription factorMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Aspergillus fumigatus drug repurposing miltefosine sphingolipids transcription factor Microbiology QR1-502 |
spellingShingle |
Aspergillus fumigatus drug repurposing miltefosine sphingolipids transcription factor Microbiology QR1-502 Thaila Fernanda dos Reis Maria Augusta Crivelente Horta Ana Cristina Colabardini Caroline Mota Fernandes Lilian Pereira Silva Rafael Wesley Bastos Maria Vitória de Lazari Fonseca Fang Wang Celso Martins Márcio L. Rodrigues Cristina Silva Pereira Maurizio Del Poeta Koon Ho Wong Gustavo H. Goldman Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
description |
ABSTRACT Aspergillus fumigatus is an important fungal pathogen and the main etiological agent of aspergillosis, a disease characterized by a noninvasive process that can evolve to a more severe clinical manifestation, called invasive pulmonary aspergillosis (IPA), in immunocompromised patients. The antifungal arsenal to threat aspergillosis is very restricted. Azoles are the main therapeutic approach to control IPA, but the emergence of azole-resistant A. fumigatus isolates has significantly increased over recent decades. Therefore, new strategies are necessary to combat aspergillosis, and drug repurposing has emerged as an efficient and alternative approach for identifying new antifungal drugs. Here, we used a screening approach to analyze A. fumigatus in vitro susceptibility to 1,127 compounds. A. fumigatus was susceptible to 10 compounds, including miltefosine, a drug that displayed fungicidal activity against A. fumigatus. By screening an A. fumigatus transcription factor null library, we identified a single mutant, which has the smiA (sensitive to miltefosine) gene deleted, conferring a phenotype of susceptibility to miltefosine. The transcriptional profiling (RNA-seq) of the wild-type and ΔsmiA strains and chromatin immunoprecipitation coupled to next-generation sequencing (ChIP-Seq) of an SmiA-tagged strain exposed to miltefosine revealed genes of the sphingolipid pathway that are directly or indirectly regulated by SmiA. Sphingolipid analysis demonstrated that the mutant has overall decreased levels of sphingolipids when growing in the presence of miltefosine. The identification of SmiA represents the first genetic element described and characterized that plays a direct role in miltefosine response in fungi. IMPORTANCE The filamentous fungus Aspergillus fumigatus causes a group of diseases named aspergillosis, and their development occurs after the inhalation of conidia dispersed in the environment. Very few classes of antifungal drugs are available for aspergillosis treatment, e.g., azoles, but the emergence of global resistance to azoles in A. fumigatus clinical isolates has increased over recent decades. Repositioning or repurposing drugs already available on the market is an interesting and faster opportunity for the identification of novel antifungal agents. By using a repurposing strategy, we identified 10 different compounds that impact A. fumigatus survival. One of these compounds, miltefosine, demonstrated fungicidal activity against A. fumigatus. The mechanism of action of miltefosine is unknown, and, aiming to get more insights about it, we identified a transcription factor, SmiA (sensitive to miltefosine), important for miltefosine resistance. Our results suggest that miltefosine displays antifungal activity against A. fumigatus, interfering in sphingolipid biosynthesis. |
format |
article |
author |
Thaila Fernanda dos Reis Maria Augusta Crivelente Horta Ana Cristina Colabardini Caroline Mota Fernandes Lilian Pereira Silva Rafael Wesley Bastos Maria Vitória de Lazari Fonseca Fang Wang Celso Martins Márcio L. Rodrigues Cristina Silva Pereira Maurizio Del Poeta Koon Ho Wong Gustavo H. Goldman |
author_facet |
Thaila Fernanda dos Reis Maria Augusta Crivelente Horta Ana Cristina Colabardini Caroline Mota Fernandes Lilian Pereira Silva Rafael Wesley Bastos Maria Vitória de Lazari Fonseca Fang Wang Celso Martins Márcio L. Rodrigues Cristina Silva Pereira Maurizio Del Poeta Koon Ho Wong Gustavo H. Goldman |
author_sort |
Thaila Fernanda dos Reis |
title |
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
title_short |
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
title_full |
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
title_fullStr |
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
title_full_unstemmed |
Screening of Chemical Libraries for New Antifungal Drugs against <named-content content-type="genus-species">Aspergillus fumigatus</named-content> Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine |
title_sort |
screening of chemical libraries for new antifungal drugs against <named-content content-type="genus-species">aspergillus fumigatus</named-content> reveals sphingolipids are involved in the mechanism of action of miltefosine |
publisher |
American Society for Microbiology |
publishDate |
2021 |
url |
https://doaj.org/article/df0e79e5ab2e41ef86dd3dc64c5b821a |
work_keys_str_mv |
AT thailafernandadosreis screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT mariaaugustacrivelentehorta screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT anacristinacolabardini screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT carolinemotafernandes screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT lilianpereirasilva screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT rafaelwesleybastos screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT mariavitoriadelazarifonseca screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT fangwang screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT celsomartins screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT marciolrodrigues screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT cristinasilvapereira screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT mauriziodelpoeta screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT koonhowong screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine AT gustavohgoldman screeningofchemicallibrariesfornewantifungaldrugsagainstnamedcontentcontenttypegenusspeciesaspergillusfumigatusnamedcontentrevealssphingolipidsareinvolvedinthemechanismofactionofmiltefosine |
_version_ |
1718439929923502080 |